Silodosin for Urinary Symptoms in Female Patients With Multiple Sclerosis
Part of paid clinical trials in Morristown, New Jersey.
- Sponsor
- Atlantic Health System
- Study ID
- NCT07614321
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- Lower Urinary Track Symptoms
- Multiple Sclerosis
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Silodosin 8 mg — DRUGSilodosin 8mg PO qd x8 weeks
- Placebo — DRUGIdentical placebo capsule, 1 capsule PO daily x8 weeks
Study Details
The goal of this clinical trial is to learn if silodosin works to treat lower urinary tract symptoms (LUTS) in female patients with multiple sclerosis (MS). It will also learn about the effect of the drug on voiding parameters. The main questions it aims to answer are: Does silodosin improve lower urinary tract symptoms based on questionnaires? Does silodosin change Uroflowmetry parameters in female patients with MS? Researchers will compare silodosin to a placebo (a look-alike substance that contains no drug) to see if silodosin works to treat LUTS in female patients with MS. Participants will: Take silodosin or a placebo every day for 8 weeks Visit the clinic before initiating the medication and after 8 weeks of taking the medication for questionnaires and tests
Key Dates
- Start date
- Apr 30, 2026
- Status verified
- May 2026
- Primary completion
- Mar 31, 2028
- Completion
- Apr 30, 2028
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: SilodosinSilodosin 8mg PO daily
- Placebo Comparator: PlaceboIdentical placebo capsule, 1 capsule PO daily
Primary Outcome Measure
Change in American Urological Association Symptom Score (AUASS) [ Time Frame: From enrollment to the end of treatment at 8 weeks ]
Central Contacts
- Mariah McKevitt, MD973-971-7267
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Atlantic Health | Morristown | New Jersey | 07960 |
Find similar trials in Morristown, NJ
Related Studies
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MSRecruiting · Kessler Foundation · West Orange, New Jersey
- A Novel Combinatory Approach to Maximize Functional Recovery of Learning and Memory in Multiple SclerosisRecruiting · Kessler Foundation · East Hanover, New Jersey
- A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)PHASE1 · Recruiting · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company · Birmingham, Alabama